Effect of reactive vaccination on meningitis epidemics in Southern Ethiopia

Summary Objectives To describe the duration and seasonality of meningitis epidemics in Southern Ethiopia and estimate the proportion of cases prevented by vaccination in order to assess the efficacy of current control strategies. Methods A descriptive study of epidemics occurring from 1999 to 2004....

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infection 2007-11, Vol.55 (5), p.425-430
Main Authors: Cuevas, L.E, Savory, E.C, Hart, C.A, Thomson, M.C, Yassin, M.A
Format: Article
Language:English
Subjects:
Africa
Biological and medical sciences
Epidemics
Ethiopia
Humans
Incidence
Infectious Disease
Infectious diseases
Medical sciences
Meningitis
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - immunology
Meningitis, Meningococcal - prevention & control
Meningococcal Vaccines - immunology
Population Surveillance
Seasons
Time Factors
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objectives To describe the duration and seasonality of meningitis epidemics in Southern Ethiopia and estimate the proportion of cases prevented by vaccination in order to assess the efficacy of current control strategies. Methods A descriptive study of epidemics occurring from 1999 to 2004. The number of cases reported in 24 districts undergoing vaccination campaigns was compared to 36 districts not receiving vaccines or where vaccines had been deployed in the zone. Results Sixty epidemics reporting a total of 5806 cases were identified. The duration of the epidemics ranged from 1 to 26 weeks with 45% lasting ≤6 weeks. Forty-one epidemics reached the WHO epidemic threshold. Seventy-one percent of the cases reported from vaccinated areas occurred in the first 6 weeks compared to 62% in unvaccinated areas and 82% for districts where vaccines had been used in the zone. Conclusions The majority of epidemics had a short duration limiting the potential to implement current vaccines effectively. Delivering vaccine to areas adjacent to an epidemic seems to increase their efficacy, however the size of this additional area needs to be better defined.
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2007.07.015